Company registration number 13666422 (England and Wales)
Ataraxia 10 Limited
Unaudited financial statements
For the period ended 31 December 2024
Ataraxia 10 Limited
Contents
Page
Statement of financial position
1 - 2
Statement of changes in equity
3
Notes to the financial statements
4 - 7
Ataraxia 10 Limited
Statement of financial position
As at 31 December 2024
31 December 2024
- 1 -
31 December 2024
30 June 2023
Notes
£
£
£
£
Fixed assets
Investments
3
1,491,791
860,665
Current assets
Debtors
4
319,690
19,296
Cash at bank and in hand
114,634
9,719
434,324
29,015
Creditors: amounts falling due within one year
5
(311,697)
(911,989)
Net current assets/(liabilities)
122,627
(882,974)
Total assets less current liabilities
1,614,418
(22,309)
Creditors: amounts falling due after more than one year
6
(1,397,050)
-
Net assets/(liabilities)
217,368
(22,309)
Capital and reserves
Called up share capital
1,001
1,000
Profit and loss reserves
216,367
(23,309)
Total equity
217,368
(22,309)
Ataraxia 10 Limited
Statement of financial position (continued)
As at 31 December 2024
31 December 2024
- 2 -
For the financial period ended 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit of its financial statements for the period in question in accordance with section 476.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The directors of the company have elected not to include a copy of the income statement within the financial statements.true
The financial statements were approved by the board of directors and authorised for issue on 7 July 2025 and are signed on its behalf by:
Mr C Parker
Director
Company registration number 13666422 (England and Wales)
Ataraxia 10 Limited
Statement of changes in equity
For the period ended 31 December 2024
- 3 -
Share capital
Profit and loss reserves
Total
Notes
£
£
£
Balance at 1 July 2022
1,000
6,024
7,024
Year ended 30 June 2023:
Loss and total comprehensive income
-
(29,333)
(29,333)
Balance at 30 June 2023
1,000
(23,309)
(22,309)
Period ended 31 December 2024:
Profit and total comprehensive income
-
239,676
239,676
Issue of share capital
1
-
1
Balance at 31 December 2024
1,001
216,367
217,368
Ataraxia 10 Limited
Notes to the financial statements
For the period ended 31 December 2024
- 4 -
1
Accounting policies
Company information
Ataraxia 10 Limited is a private company limited by shares incorporated in England and Wales. The registered office is Venture House, St. Leonards Road, Allington, Maidstone, ME16 0LS.
1.1
Reporting period
The financial statements presented are for an extended period. The period was extended to bring the year end in line with other connected companies. Therefore, the comparative results for the year ended 30 June 2023 are not entirely comparable.
1.2
Accounting convention
These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.
The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.
The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.
1.3
Turnover
Revenue comprises sales of services provided to customers. Revenue is recognised when performance obligations are satisfied and the control of goods or services is transferred to the buyer.
Revenue from contracts for the provision of professional services is recognised by reference to the stage of completion when the stage of completion, costs incurred and costs to complete can be estimated reliably. The stage of completion is calculated by comparing costs incurred, mainly in relation to contractual hourly staff rates and materials, as a proportion of total costs. Where the outcome cannot be estimated reliably, revenue is recognised only to the extent of the expenses recognised that are recoverable.
1.4
Fixed asset investments
Interests in subsidiaries are initially measured at cost and subsequently measured at cost less any accumulated impairment losses. The investments are assessed for impairment at each reporting date and any impairment losses or reversals of impairment losses are recognised immediately in profit or loss.
A subsidiary is an entity controlled by the company. Control is the power to govern the financial and operating policies of the entity so as to obtain benefits from its activities.
1.5
Cash and cash equivalents
Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.
Ataraxia 10 Limited
Notes to the financial statements (continued)
For the period ended 31 December 2024
1
Accounting policies
(Continued)
- 5 -
1.6
Financial instruments
The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.
Financial instruments are recognised in the company's statement of financial position when the company becomes party to the contractual provisions of the instrument.
Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.
Basic financial assets
Basic financial assets, which include debtors and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.
Classification of financial liabilities
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.
Basic financial liabilities
Basic financial liabilities, including bank loans and loans from fellow group companies, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.
Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.
Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities.
1.7
Equity instruments
Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.
1.8
Taxation
The tax expense represents the tax currently payable.
Current tax
The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the income statement because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.
Ataraxia 10 Limited
Notes to the financial statements (continued)
For the period ended 31 December 2024
- 6 -
2
Employees
The average monthly number of persons (including directors) employed by the company during the period was:
2024
2023
Number
Number
Total
0
3
3
Fixed asset investments
2024
2023
£
£
Shares in group undertakings and participating interests
1,491,791
860,665
Movements in fixed asset investments
Shares in associates
£
Cost or valuation
At 1 July 2023
860,665
Additions
631,126
At 31 December 2024
1,491,791
Carrying amount
At 31 December 2024
1,491,791
At 30 June 2023
860,665
4
Debtors
2024
2023
Amounts falling due within one year:
£
£
Trade debtors
20,495
11,296
Other debtors
299,195
8,000
319,690
19,296
Ataraxia 10 Limited
Notes to the financial statements (continued)
For the period ended 31 December 2024
- 7 -
5
Creditors: amounts falling due within one year
2024
2023
£
£
Taxation and social security
26,602
9,780
Other creditors
285,095
902,209
311,697
911,989
6
Creditors: amounts falling due after more than one year
2024
2023
£
£
Other creditors
1,397,050
7
Related party transactions
At the year end date the company owed £1,397,050 (2023 - £685,000) to P. G. Cullum. As at the year end date unpaid interest of £282,484 (2023 - £75,053) was accrued on these loan notes.
At the year end date the company was due £299,194 (2023 - £8,000) from a connected company. This is unsecured and is repayable on demand.